Academic History

Alessandro di Federico, MD, is a Medical Oncologist and Research Fellow at Memorial Sloan Kettering Cancer Center, New York, NY. He is also a PhD student at the University of Bologna, Bologna, Italy, and previously served as a Visiting Scientist at Dana-Farber Cancer Institute, Boston, MA. Dr di Federico obtained his medical degree from the University of Parma, Parma, Italy, and completed his Medical Oncology specialization at the University of Bologna.

Dr di Federico is an active member of several international organizations. He has been selected as a meeting correspondent by the Society for Immunotherapy of Cancer and has served as an expert envoy at the European Society for Medical Oncology (ESMO) Immuno-Oncology congress.

Speaking on biomarkers and personalized medicine in thoracic oncology

Dr di Federico’s research focuses on lung cancers, with an emphasis on molecular biomarkers and immunotherapy in non-small cell lung cancer (NSCLC). His work has investigated the genomic drivers of NSCLC and mechanisms of acquired resistance to targeted therapies, including EGFR-directed treatment. He is also interested in identifying markers of response and resistance to anti-PD-1/PD-L1 therapies with the aim of determining which patients are likely to benefit most from immunotherapy-based treatment.